OLIX
OLIX Raises $312M Series B for Frontier AI Inference Infrastructure
OLIX announced $312M in Series B financing on August 3, 2026. OLIX raised a $312 million Series B at a $3.3 billion valuation to build infrastructure for frontier AI inference, with Arm and Hudson River Trading among the participants.
Round details
The financing includes backing from Arm, Hudson River Trading, Fundomo, Hummingbird Ventures, Crane, Plural, Creandum, Phoenix Court. The company reported a $3.3B valuation alongside the transaction.
- Round: Series B
- Capital announced: $312M
How the company plans to use the capital
OLIX said the financing funds delivery of its DX-1 decode accelerator to its first customers by the second half of 2027, the build-out of its wider custom silicon platform, and the manufacturing and supply chain commitments needed to scale inference hardware.
Why this matters for GTM teams
The round points to investor interest in AI inference hardware, an area where OLIX says it designs every part of its systems, from the chips and lasers to the network that connects them.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: OLIX Series B announcement.
Company Info
Investors (8)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


